Clinical Trial

A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.

Name: A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors. — clinical trial record (NCT06487455)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of SPH7485 tablets in patients with advanced solid tumors.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2024-06-27; most recent amendment 2025-08-15.

Status change: Not Yet Recruiting → Recruiting 2024-08-05

Trial Details

NCT Number	NCT06487455
Lead Sponsor	Shanghai Pharmaceuticals Holding Co., Ltd
Conditions	Advanced Solid Tumor
Enrollment	170 participants
Start Date	2024-08-06
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-17